The digital healthcare firm posted a near-50% jump in quarterly revenue, but profits plunged over 90% year-on-year, highlighting a stark profitability disconnect.
Health X Platform's Q1 FY27 results show a tale of two trends: strong revenue growth of 49.7% YoY was completely overshadowed by a 92.5% collapse in profit, squeezing margins to just 0.4%.
Health X Platform delivered a quarter of stark contrasts. While revenue growth accelerated impressively, profitability collapsed, leaving the company's earnings power in question.
The digital healthcare supply chain company reported revenue of ₹446.85 crore for Q1 FY27, a robust 49.7% increase from the same quarter last year and a 19.5% sequential improvement. However, profit plummeted 92.5% year-on-year to just ₹1.99 crore, down from ₹26.59 crore in Q1 FY26. This dramatic divergence crushed the net profit margin, which fell 850 basis points to a wafer-thin 0.4%.
A look at the last five quarters reveals the underlying volatility in the company's performance.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 446.85YoY +50% | 373.78 | 298.43 |
| Profit (₹ Cr) | 1.99YoY -93% | -12.97 | 26.59 |
| Net Profit Margin (%) | 0.4YoY -96% | -3.5 | 8.9 |
This pattern shows revenue has been on a steady upward climb, but profits have been erratic, dipping into losses in two of the last four quarters. The trailing twelve-month (TTM) figures underscore the challenge, with a cumulative net loss of ₹26.05 crore on revenue of ₹1,467.69 crore, resulting in a negative TTM net profit margin of -1.8%.
Key Points
For Health X Platform, the immediate task is clear: it must find a way to convert its impressive top-line momentum into sustainable bottom-line results.
Live Chart
· HEALTHX
(BSE)
ISIN: INE019J01013
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.